Monitoring and maintaining health — OCR GCSE Biology
Test yourself on Monitoring and maintaining health with OCR GCSE practice questions.
7 days Premium · Then free forever · No card, no charge
Monitoring and maintaining health explained
Drug development proceeds through structured preclinical and clinical phases to establish safety, efficacy, and dosage.
Read the full explanation
Preclinical testing takes place in laboratory settings, assessing the chemical on isolated human cells, cultured tissues, and live animals to determine basic efficacy, toxicity, and safe dosage ranges. If cleared, clinical trials commence on humans: Phase 1 administers very low doses to healthy volunteers to check safety and side effects; Phase 2 tests the drug on volunteer patients to evaluate clinical efficacy and refine dosage; Phase 3 conducts large-scale, double-blind trials comparing the drug against a placebo, where neither patients nor doctors know who receives the active drug, eliminating psychological and observer bias.
Your focus
- Describe preclinical laboratory testing using cells, tissues, and live animal models.
- Outline the phases of human clinical trials assessing drug safety, efficacy, and dosage.
- Explain the design and rationale of double-blind, placebo-controlled clinical trials in eliminating scientific bias.
Monitoring and maintaining health exam tips
Marking Points
- Describe preclinical testing in laboratories using cultured human cells, tissues, and live animals to evaluate toxicity, efficacy, and dosage.
- Describe clinical trials Phase 1 on healthy human volunteers at very low doses to test safety and side effects.
- Describe clinical trials Phase 2 and 3 on patients suffering from the target disease to test efficacy, determine optimum dosage, and monitor rare side effects.
- Explain double-blind placebo-controlled trials, where neither patients nor doctors know who receives the real drug, eliminating bias.
Examiner Tips
- 💡Clearly distinguish between toxicity (is it harmful?), efficacy (does it work?), and dosage (how much is needed?).
- 💡Explain that double-blind trials eliminate psychological bias from patients (placebo effect) and subjective bias from doctors analysing results.
Common Mistakes
- Thinking Phase 1 clinical trials test whether the drug cures the illness, rather than checking safety on healthy volunteers.
- Believing a placebo is a poison, rather than an inert substance (such as a sugar pill) containing no active medicine.